ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

CANCER RESIDUE OF THE THYROID GLAND AFTER THE ORGAN PRESERVING OPERATIONS

AUTHORS:

Mykhaylichenko V. Yu., Zhadko S. I., Bezrukov O. F., Pritulo L. F., Samarin S. A., Sulima A. N.

ABSTRACT:

Abstract: Aim. To study the percentage of cancer in the residue of the thyroid gland after organ-preserving surgery on the thyroid gland for benign pathology. Materials and methods: The study was based on the analysis of 2431 histories of patients who underwent various surgical interventions in connection with benign diseases of the thyroid gland more than 10 years ago. Among these patients 1948 patients were female, which is 80.1% of total amount of patients. The age of patients ranged between 18 to 74 years, an average of 56.7 years. The patients were monitored by the staff of the centers with terms from 5 to 30 years. Naturally, the purity of the experience was disturbed by the fact that we selected only those patients who were recorded in the database and the archive of hospitals, of course this is not all treated and not all were observed in the remote postoperative period. Results: It has been established that residual cancer occurs in 3% of all cases of operated patients and in 25.9% of patients who had a thyroid residue. It should be emphasized that most often Residual cancer occurs in patients with diffuse toxic goiter. On the basis of what the authors believes that in case of the hormonal instability of the thyroid residue with diffuse toxic goiter, thyroidectomy should be performed. Conclusions: The main factor in the recurrence of differentiated thyroid cancer is organ-preserving operations in any volume, as well as not removed lymph nodes with non-diagnosable metastases. Although Dissimilar data after 5years -30 occurrence of cancer in the remainder of the thyroid gland is found according to our observations at 25,9% of cases, when it occurs in DTZ 8, 9% than at other benign pathologies of the thyroid gland. Key words: cancer of the residual thyroid gland, volume of operation.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.